Patients with higher levels of both VEGF-C and CNTN-1 were more likely than those with low or intermediate levels of these proteins to have more advanced stage, more severe lymph node metastasis, lymphatic invasion, and serosa invasion. This evidence concerns the gene VEGFC and metastatic malignant neoplasm in the lymph nodes.